Table 1 Patient and disease characteristics at baseline
Hizentra N = 117 | |
|---|---|
Patient characteristics | 117 |
Male gender, n (%) | 61 (52.1 %) |
Age (years), N | 117 |
Mean ± SD | 52.0 ± 23.9 |
Median [range] | 58.0 (2.0–90.0) |
Weight (kg), N | 115 |
Mean ± SD | 63.0 ± 20.6 |
Median [range] | 63.0 (11.0–115.0) |
Body mass index (kg/m2), N | 110 |
Mean ± SD | 23.4 ± 5.0 |
Median [range] | 23.4 (13.6–33.8) |
Socio-professional status, N | 117 |
Child in elementary school, n (%) | 14 (12.0 %) |
Child in middle/high school, n (%) | 4 (3.4 %) |
Not workinga, n (%) | 63 (53.8 %) |
Adult employed, n (%) | 30 (25.6 %) |
Other, n (%) | 6 (5.1 %) |
Diagnosis, N | 117 |
Primary immunodeficiency, n (%) | 60 (51.3 %) |
Secondary immunodeficiency, n (%) | 57 (48.7 %) |
Myeloma, n (%) | 13 (22.8 %) |
Chronic lymphocytic leukemia, n (%) | 18 (31.6 %) |
Other, n (%) | 26 (45.6 %) |
Duration of immunodeficiency (years), N | 114 |
Mean ± SD | 5.8 ± 5.9 |
Median [range] | 4.3 [0.1;36.9] |
Status of immunodeficiency, N | 49 |
Progression, n (%) | 11 (22.4 %) |